MYL9 and neoplasm: Among the potentially interacted proteins of PRPF19 that possessed the highest score listed in Fig. 3A (right panel), we found that MYL9 was an activator in tumor metastasis and predicted worse outcomes in CRC (Supplementary Fig. 4A, B).